Total Company Value: ABVC BioPharma, Inc (ABVC)

ABVC BioPharma focuses on the global expansion of its plant-based product line for treating ADHD and depression through clinical trials. Market price action reflects an Enterprise Value of 32.54. Market capitalization is supported by milestone payments from pharma partners for innovation success, while the company derives its primary revenue from licensing agreements for the development of drugs targeting psychiatric disorders and oncology.

ABVC (abvcpharma.com) Total Company Value history from 11/23/2025 to 10/26/2026

ABVC BioPharma (ABVC) - metric breakdowns and financial figures

- price and consensus price forecast:

Price Chart ABVC BioPharma Inc.|ABVC - Consensus Target

- market capitalization data:

Market Value ABVC BioPharma|ABVC - Enterprise Value

- book capitalization data:

Accounting Value per Share ABVC BioPharma|ABVC - Company Book Value|Market Capitalization to Net Assets abvcpharma.com|ABVC - Company Total Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio ABVC BioPharma|ABVC - Long-Term Debt to Capital|Short-Term Debt to Capital abvcpharma.com|ABVC - Company Debts|Debt to Net Assets Ratio ABVC BioPharma

Comprehensive company analysis:ABVC BioPharma Inc. (ABVC)

ABVC BioPharma develops high-risk, early-stage biotechnological projects. The enterprise value sums the market capitalization and net debt, reflecting the total acquisition price of the business. Analyzing the enterprise value structure allows for the identification of hidden risk overvaluation during market volatility. For the issuer, this indicator is critical due to potential capital shortages for research. The trend of this metric demonstrates the current investor consensus regarding the viability of the developments.

Competitor analysis for ABVC BioPharma

HLN - Total Company Value|KVUE - Real Price to Acquire Entire Company|VRNA - Total Company Value|MENS (Jyong Biotech Ltd) - Enterprise Value|LGND (ligand.com) - Real Price to Acquire Entire Company|Total Company Value Amneal AMRX|Full Business Value Perrigo Company PLC|Alvotech Corp (ALVO) - Enterprise Value|Value Adjusted for Debt and Cash Liquidia Inc. (LQDA)|Enterprise Value GLPG (Galapagos NV)|anipharmaceuticals.com - Enterprise Value|Total Company Value MannKind (MNKD)|AMPH: Value Adjusted for Debt and Cash|PCRX (Pacira) - Total Company Value|ARS Corp (SPRY) - Real Price to Acquire Entire Company|TBPH (Theravance Biopharma) - Enterprise Value|Enterprise Value aquestive.com (AQST)|scPharmaceuticals Inc. (SCPH) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash TECX (tectonictx.com)|TNXP: Total Company Value|SXTC - Total Enterprise Value|Real Price to Acquire Entire Company Eupraxia Pharma EPRX|BHST - Aggregate Business Value|Enterprise Value eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Value Adjusted for Debt and Cash|Enterprise Value ENTX (Entera Bio Ltd)|Total Enterprise Value HYFT|Cumberland Pharmaceuticals (CPIX) - Total Company Value|Value Adjusted for Debt and Cash quantumbiopharma.com (QNTM)|Enterprise Value FGEN (FibroGen)|Enterprise Value Telomir Pharmaceuticals Inc TELO|RANI - Enterprise Value|Synergy CHC Corp (SNYR) - Total Company Value|rallybio.com (RLYB) - Real Price to Acquire Entire Company|Lexaria Bioscience Corp. (LEXX) - Total Company Value|Enterprise Value PULM|Real Price to Acquire Entire Company Pheton (PTHL)|Aptorum Group Limited (APM) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Lyra Therapeutics Inc (LYRA)|Enterprise Value Impact BioMedical IBO|Total Company Value TNF Pharmaceuticals Inc. TNFA|Enterprise Value YCBD (cbdMD Corp)|PRFX: Company Buyout Price|Total Company Value CYTO|LIPO (Lipella Pharma) - Total Enterprise Value|Total Company Value OptiNose, Inc. OPTN|Full Business Value pieris.com|Procaps (PROC) - Enterprise Value|Value Adjusted for Debt and Cash Petros Pharmaceuticals Inc (PTPI)|Enterprise Value QLI (Qilian International Holding Group Limited)|ACELYRIN Inc. - Enterprise Value|Total Company Value TFF Pharmaceuticals (TFFP)